NaaS Technology Engages Investors at Major Conferences in Shenzhen
February 12, 2025 - 16:50
NaaS Technology is set to engage with potential investors at prominent conferences hosted by Zheshang Securities and Founder Securities in Shenzhen. This strategic move highlights the company's commitment to showcasing its growth opportunities within the rapidly expanding electric vehicle (EV) charging sector.
As the demand for EVs continues to soar, NaaS Technology aims to capitalize on this trend by enhancing its charging infrastructure and services. The conferences will provide a platform for the company to present its innovative solutions and discuss the future of EV charging in China, a market that is becoming increasingly competitive and dynamic.
Industry experts anticipate that NaaS Technology's participation will not only attract investment but also foster partnerships that could accelerate its growth trajectory. The company is poised to play a pivotal role in shaping the future of sustainable transportation, making these investor meetings a crucial step in its expansion strategy.
MORE NEWS
August 8, 2026 - 01:15
19th century real estate agents used ‘peepshow’ technology to sell glitzy mansionBefore Zillow, before glossy real estate brochures, there was the cosmorama. In the 1840s, wealthy home sellers and developers in Europe and America turned to these handheld viewing boxes to show...
August 7, 2026 - 06:56
AI used to create viruses not found in nature for first timeA team of researchers in the United States has announced the creation of 16 new viruses that do not exist in nature, marking the first time artificial intelligence has been used to design such...
August 6, 2026 - 19:49
MatSing Details Manufacturing Technology to Improve Satellite Antenna PerformanceMatSing has introduced a proprietary manufacturing process designed to boost the capabilities of multibeam and wideband antennas used in satellite communications. The company says the new technique...
August 6, 2026 - 03:31
FDA approves Moderna’s mRNA flu vaccine, the first to use the technologyThe U.S. Food and Drug Administration has given the green light to Moderna`s new influenza vaccine, marking the first time a flu shot built on messenger RNA technology has been licensed. The...